INDOMETIN

Main information

  • Trade name:
  • INDOMETIN 50 mg capsule, hard
  • Dosage:
  • 50 mg
  • Pharmaceutical form:
  • capsule, hard
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • INDOMETIN 50 mg capsule, hard
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Indometacin
  • Product summary:
  • Suitability for use in older adult patients Indometacinum Avoid using in elderly persons. Do not use in severe renal insufficiency. Significant adverse effects include gastrointestinal bleeding, renal insufficiency and its worsening, elevated blood pressure, cardiac insufficiency, dizziness and psychosis. Take interactions into account, especially with other drugs that increase the risk of bleeding and with antihypertensive agents.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 6216
  • Authorization date:
  • 25-08-2009
  • Last update:
  • 21-02-2018